MDT

96.1

-0.44%↓

A

137.81

-0.48%↓

VEEV

224.76

+0.38%↑

HQY

92.67

-0.47%↓

PHR.US

16.99

-0.18%↓

MDT

96.1

-0.44%↓

A

137.81

-0.48%↓

VEEV

224.76

+0.38%↑

HQY

92.67

-0.47%↓

PHR.US

16.99

-0.18%↓

MDT

96.1

-0.44%↓

A

137.81

-0.48%↓

VEEV

224.76

+0.38%↑

HQY

92.67

-0.47%↓

PHR.US

16.99

-0.18%↓

MDT

96.1

-0.44%↓

A

137.81

-0.48%↓

VEEV

224.76

+0.38%↑

HQY

92.67

-0.47%↓

PHR.US

16.99

-0.18%↓

MDT

96.1

-0.44%↓

A

137.81

-0.48%↓

VEEV

224.76

+0.38%↑

HQY

92.67

-0.47%↓

PHR.US

16.99

-0.18%↓

Search

ICU Medical Inc

Chiusa

SettoreSettore sanitario

146.94 -0.58

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

145.84

Massimo

148.34

Metriche Chiave

By Trading Economics

Entrata

-39M

-3.4M

Vendite

-12M

537M

Margine di Profitto

-0.632

Dipendenti

15,000

EBITDA

-40M

67M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+17.33% upside

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

629M

3.7B

Apertura precedente

147.52

Chiusura precedente

146.94

Notizie sul Sentiment di mercato

By Acuity

50%

50%

149 / 374 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Very Strong Bullish Evidence

ICU Medical Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

29 dic 2025, 22:03 UTC

I principali Market Mover

Mining Stocks Slip Near the End of Stellar Year

29 dic 2025, 15:57 UTC

I principali Market Mover

Praxis Shares Rise on Ulixacaltamide Breakthrough Designation

29 dic 2025, 23:43 UTC

Discorsi di Mercato

Nikkei May Decline; Yen in Focus -- Market Talk

29 dic 2025, 23:38 UTC

Acquisizioni, Fusioni, Takeovers

Manus: Will Continue to Operate From Singapore

29 dic 2025, 23:38 UTC

Acquisizioni, Fusioni, Takeovers

Manus: Will Continue to Sell, Operate Product Subscription Service Through App, Website

29 dic 2025, 23:37 UTC

Acquisizioni, Fusioni, Takeovers

Meta Platforms: Will Integrate Manus Service Into Products

29 dic 2025, 23:36 UTC

Acquisizioni, Fusioni, Takeovers

Meta Platforms: Will Continue to Operate, Sell Manus Service

29 dic 2025, 23:36 UTC

Acquisizioni, Fusioni, Takeovers

Meta Platforms: Manus's Talent to Join Team to Deliver General-Purpose Agents Across Consumer, Business Products

29 dic 2025, 23:35 UTC

Acquisizioni, Fusioni, Takeovers

Manus to Join Meta Platforms

29 dic 2025, 21:33 UTC

Acquisizioni, Fusioni, Takeovers

Origin: Raise Values Kraken at US$8.65 Billion

29 dic 2025, 21:33 UTC

Acquisizioni, Fusioni, Takeovers

Origin: Octopus Targeting Kraken Separation by Mid 2026

29 dic 2025, 21:31 UTC

Acquisizioni, Fusioni, Takeovers

BlueScope: Rezoning Will Allow for Range of Commercial, Industrial Development Uses

29 dic 2025, 21:31 UTC

Acquisizioni, Fusioni, Takeovers

BlueScope Also Says Land Adjacent to Port Kembla Steelworks Rezoned to Special Purpose

29 dic 2025, 21:30 UTC

Acquisizioni, Fusioni, Takeovers

Origin's Kraken Stake to Remain at 22.7%

29 dic 2025, 21:30 UTC

Acquisizioni, Fusioni, Takeovers

Origin Will Continue to Hold Its 22.7% Interest in Octopus

29 dic 2025, 21:30 UTC

Acquisizioni, Fusioni, Takeovers

BlueScope: Guidance Reflects Sustained Strength of Operating Performance in Recent Months

29 dic 2025, 21:30 UTC

Acquisizioni, Fusioni, Takeovers

Origin: Additional Interest Offsets Dilution From Raise

29 dic 2025, 21:30 UTC

Acquisizioni, Fusioni, Takeovers

BlueScope Doesn't Expect Material Impact on 1H Guidance Range

29 dic 2025, 21:29 UTC

Acquisizioni, Fusioni, Takeovers

Origin Waiving Australia Exclusivity to Kraken in Exchange for Additional 1.5% Equity Interest

29 dic 2025, 21:29 UTC

Acquisizioni, Fusioni, Takeovers

BlueScope Expects to Complete Property Sale for A$76 Million Consideration

29 dic 2025, 21:29 UTC

Acquisizioni, Fusioni, Takeovers

BlueScope Expects to Complete Property Sale in 2H of FY 2026

29 dic 2025, 21:28 UTC

Acquisizioni, Fusioni, Takeovers

BlueScope: Selling Residentially Zoned Land in West Dapto to Large Homebuilder

29 dic 2025, 21:28 UTC

Acquisizioni, Fusioni, Takeovers

Origin: Kraken's Raise Paves Way for Separation From Octopus Energy

29 dic 2025, 21:28 UTC

Acquisizioni, Fusioni, Takeovers

Origin: Kraken to Raise Total US$1 Billion From New, Existing Investors

29 dic 2025, 21:28 UTC

Acquisizioni, Fusioni, Takeovers

BlueScope Steel Exchanges Contracts for Sale of 33 Hectares of Land in West Dapto

29 dic 2025, 21:27 UTC

Acquisizioni, Fusioni, Takeovers

Origin Energy to Invest US$140M in Kraken's Standalone Equity Raise

29 dic 2025, 20:22 UTC

Discorsi di Mercato

Oil Rebounds As Russia-Ukraine War Seen Continuing -- Market Talk

29 dic 2025, 20:14 UTC

Discorsi di Mercato

U.S. Natural Gas Futures Rise As Front Month Expires -- Market Talk

29 dic 2025, 20:02 UTC

Acquisizioni, Fusioni, Takeovers

Union Pacific--Norfolk Southern Merger Targets Trucking Market Share -- Barrons.com

29 dic 2025, 17:36 UTC

Discorsi di Mercato

U.S. Natural Gas Inventories Swing to Deficit Vs. 5-Year Average -- Market Talk

Confronto tra pari

Modifica del prezzo

ICU Medical Inc Previsione

Obiettivo di Prezzo

By TipRanks

17.33% in crescita

Previsioni per 12 mesi

Media 173.5 USD  17.33%

Alto 175 USD

Basso 172 USD

Basato su 3 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per ICU Medical Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

3 ratings

2

Acquista

1

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

137.16 / N/ASupporto e resistenza

A breve termine

Very Strong Bullish Evidence

A termine intermedio

Bullish Evidence

A lungo termine

Strong Bearish Evidence

Sentiment

By Acuity

149 / 374 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo ICU Medical Inc

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.
help-icon Live chat